MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,664,560 | -90.3% | 290,808 | -86.0% | 0.01% | -90.6% |
Q2 2023 | $47,999,869 | -3.5% | 2,070,745 | -3.3% | 0.11% | -14.5% |
Q1 2023 | $49,725,604 | +9825.3% | 2,140,577 | +8056.1% | 0.12% | +6100.0% |
Q3 2022 | $501,000 | -21.2% | 26,245 | -25.0% | 0.00% | 0.0% |
Q2 2022 | $636,000 | -92.1% | 35,000 | -89.1% | 0.00% | -92.3% |
Q1 2022 | $8,091,000 | +13.3% | 321,067 | +45.2% | 0.03% | -13.3% |
Q3 2021 | $7,142,000 | +9.8% | 221,193 | +3.6% | 0.03% | -6.2% |
Q1 2021 | $6,503,000 | -38.2% | 213,566 | -59.9% | 0.03% | -44.8% |
Q4 2020 | $10,522,000 | +310.5% | 532,095 | +170.8% | 0.06% | +205.3% |
Q3 2020 | $2,563,000 | +54.2% | 196,522 | +34.1% | 0.02% | +35.7% |
Q2 2020 | $1,662,000 | +75.3% | 146,581 | +349.5% | 0.01% | +100.0% |
Q4 2018 | $948,000 | -50.7% | 32,610 | -21.9% | 0.01% | -22.2% |
Q3 2018 | $1,921,000 | +156.5% | 41,760 | +64.7% | 0.01% | +200.0% |
Q1 2018 | $749,000 | +1.8% | 25,355 | +18.4% | 0.00% | +50.0% |
Q4 2017 | $736,000 | +242.3% | 21,418 | +66.2% | 0.00% | +100.0% |
Q4 2016 | $215,000 | – | 12,886 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |